RxSight (RXST) Change in Receivables (2020 - 2026)
RxSight posted quarterly Change in Receivables of -$936000.0 for Q1 2026, down 200.86% year-on-year from $928000.0 in Q1 2025, and down 18.78% on a QoQ basis from -$788000.0 in Q4 2025.
RxSight (RXST) has 7 years of Change in Receivables data on file, last reported at -$936000.0 in Q1 2026.
- For the quarter ending Q1 2026, Change in Receivables fell 200.86% year-over-year to -$936000.0; the trailing twelve-month figure through Mar 2026 stood at -$8.5 million (down 190.03% YoY), and the FY2025 full-year result was -$6.7 million, down 167.89% from the prior year.
- Change in Receivables for Q1 2026 stood at -$936000.0, down from -$788000.0 in the prior quarter.
- Across five years, Change in Receivables topped out at $5.0 million in Q4 2023 and bottomed at -$3.9 million in Q3 2025.
- The 5-year median for Change in Receivables is $1.3 million (2022), against an average of $1.0 million.
- The widest annual swing landed in 2024, when Change in Receivables jumped 566.45%; it then tumbled 1120.94% in 2025.
- A 5-year view of Change in Receivables shows it stood at $1.9 million in 2022, then surged by 160.31% to $5.0 million in 2023, then retreated by 7.05% to $4.7 million in 2024, then tumbled by 116.83% to -$788000.0 in 2025, then slipped by 18.78% to -$936000.0 in 2026.
- The last three Change in Receivables figures came in at -$936000.0 (Q1 2026), -$788000.0 (Q4 2025), and -$3.9 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 42.00 Mn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | -444.00 Mn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | -13.00 Mn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 117.00 Mn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 117.90 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | -124.60 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -141.00 Mn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 123.50 Mn |
| 10 | RxSight | 215.82 Mn | -2.06 Mn | 23.50 Mn | -936,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -936,000.00 |
| Mar 31, 2026 | -936,000.00 |
| Dec 31, 2025 | -788,000.00 |
| Dec 31, 2025 | -788,000.00 |
| Sep 30, 2025 | -3.91 Mn |
| Sep 30, 2025 | -3.91 Mn |
| Jun 30, 2025 | -2.89 Mn |
| Jun 30, 2025 | -2.89 Mn |
| Mar 31, 2025 | 928,000.00 |
| Mar 31, 2025 | 928,000.00 |
| Dec 31, 2024 | 4.68 Mn |
| Dec 31, 2024 | 4.68 Mn |
| Sep 30, 2024 | -320,000.00 |
| Sep 30, 2024 | -320,000.00 |
| Jun 30, 2024 | 4.17 Mn |
| Jun 30, 2024 | 4.17 Mn |
| Mar 31, 2024 | 1.27 Mn |
| Mar 31, 2024 | 1.27 Mn |
| Dec 31, 2023 | 5.04 Mn |
| Dec 31, 2023 | 5.04 Mn |
| Sep 30, 2023 | 1.95 Mn |
| Sep 30, 2023 | 1.95 Mn |
| Jun 30, 2023 | 626,000.00 |
| Jun 30, 2023 | 626,000.00 |
| Mar 31, 2023 | 1.71 Mn |
| Mar 31, 2023 | 1.71 Mn |
| Dec 31, 2022 | 1.94 Mn |
| Dec 31, 2022 | 1.94 Mn |
| Sep 30, 2022 | 2.14 Mn |
| Sep 30, 2022 | 2.14 Mn |
| Jun 30, 2022 | 1.26 Mn |
| Jun 30, 2022 | 1.26 Mn |
| Mar 31, 2022 | 764,000.00 |
| Mar 31, 2022 | 764,000.00 |
| Dec 31, 2021 | 504,000.00 |
| Dec 31, 2021 | 504,000.00 |
| Sep 30, 2021 | 421,000.00 |
| Sep 30, 2021 | 421,000.00 |
| Jun 30, 2021 | 1.67 Mn |
| Jun 30, 2021 | 1.67 Mn |
| Mar 31, 2021 | -600,000.00 |
| Mar 31, 2021 | -600,000.00 |
| Dec 31, 2020 | 1.43 Mn |
| Dec 31, 2020 | 1.43 Mn |
| Sep 30, 2020 | 475,000.00 |
| Sep 30, 2020 | 475,000.00 |